The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R)-N-[(3S)-8-methoxy-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-N'-propyl-2-(3,3,3-trifluoropropyl)butanediamide ID: ALA5283121
Max Phase: Preclinical
Molecular Formula: C27H31F3N4O4
Molecular Weight: 532.56
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCNC(=O)C[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2ccc(OC)cc2N(C)C1=O
Standard InChI: InChI=1S/C27H31F3N4O4/c1-4-14-31-22(35)15-18(12-13-27(28,29)30)25(36)33-24-26(37)34(2)21-16-19(38-3)10-11-20(21)23(32-24)17-8-6-5-7-9-17/h5-11,16,18,24H,4,12-15H2,1-3H3,(H,31,35)(H,33,36)/t18-,24-/m1/s1
Standard InChI Key: IVQHGYMDJDMREI-HOYKHHGWSA-N
Molfile:
RDKit 2D
38 40 0 0 0 0 0 0 0 0999 V2000
-2.0538 0.3354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3396 -0.0775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3396 -0.9048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0519 -1.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6834 -1.4217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1249 -1.2307 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4796 -0.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1111 0.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6954 0.4420 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9094 1.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6964 0.8506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3072 -0.4823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7209 0.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5486 0.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9624 0.9510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7901 0.9510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2040 1.6678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2040 0.2341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9623 -0.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5486 -1.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9623 -1.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3072 0.9510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8975 -2.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3125 -2.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5267 -3.6037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3266 -3.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9102 -3.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7006 -2.4364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5484 -2.6324 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7898 -1.9157 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1764 -2.7151 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.7706 -0.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7706 -0.9085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4873 0.3359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2040 -0.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7900 2.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2038 3.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7899 3.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
3 5 1 0
5 6 2 0
7 6 1 0
8 7 1 0
2 9 1 0
9 8 1 0
9 10 1 0
8 11 2 0
7 12 1 1
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
14 19 1 1
19 20 1 0
20 21 1 0
13 22 2 0
5 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
21 29 1 0
21 30 1 0
21 31 1 0
1 32 2 0
32 33 1 0
33 4 2 0
32 34 1 0
34 35 1 0
17 36 1 0
36 37 1 0
37 38 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 532.56Molecular Weight (Monoisotopic): 532.2297AlogP: 3.83#Rotatable Bonds: 10Polar Surface Area: 100.10Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.15CX Basic pKa: 0.45CX LogP: 3.48CX LogD: 3.48Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.49Np Likeness Score: -0.28
References 1. Lee S, Love MS, Modukuri R, Chatterjee AK, Huerta L, Lawson AP, McNamara CW, Mead JR, Hedstrom L, Cuny GD.. (2023) Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition., 90 [PMID:37196868 ] [10.1016/j.bmcl.2023.129328 ]